Banter and General Comments, page-1785

First 1785 Last

Share
Profile

Follow
Dancing

4,764 Posts.

477

24/11/18

17:47

Post #: 36628461
Share

Originally posted by jake99aus ↑

It is interesting that two substantial/critical announcements by GXY have not occurred in the timely manner outlined by Galaxy over the previous two months. I highly doubt one is delayed by allocation of a piece of paper from the local "Titles Department".
The other announcement is for "Strategic Partner" for Sal DE Vida.
The timing of both these deals has been substantially missed by Galaxy. Why? - Why the Silence? - Why not an Update?
There is one common thread to both these announcements and that is Posco! My belief this relationship with Posco is continuing to evolve faster and further that has been so far alluded to.
I don't think for one minute this would be a takeover from Posco (too many complimentary synergies by both parties) but I would be very confident now that both deals are going to end up as "one-and-the-same" on an expanded basis!
cheers Jake

"Buy-in Partner"

It very interesting that Galaxy management are so quiet, given the negotiations that are ongoing. We know that the non binding offers have been made (first week of Nov I believe) and that the analysis is currently underway to determine the best case made from the remaining companies in the running. This silent auction will bring a strong result for galaxy and shareholders. I think there is a lot more to this deal than what we know/have been told.

Have we received a take over?

Expand

Um, the SDV announcement is not due until the end of the year. So it hasn’t been missed.

The POSCO cash was assumed to be “in the bag”, as the money was in escrow, so an announcement of that receipt may not have warranted an announcement.

GXY Price at posting: $2.62 Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 19,247 more messages in this thread...

First 1785 Last

Add GXY (ASX) to my watchlist

Banter and General Comments, page-1785

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News